1
Department of Endocrinology and Metabolism, Mofid Children’s Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2
Mofid Children’s Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3
Department of Immunology, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4
Department of Immunology and Allergy, Mofid Children’s Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
5
Pediatric Infections Research Center, Research Institute for Children Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran
How to Cite:
Alaei
M, Alizadeh Najjarbashi
F, Shakiba
M, Rasouli
S, Saneifard
H, et al. Evaluation of Phagocytic Component of the Immune System in Patients with Organic Acidemia. Arch Pediatr Infect Dis. 2017;5(4):e61624.
doi: 10.5812/pedinfect.61624.
ARTICLE INFORMATION
Archives of Pediatric Infectious Diseases:
5 (4); e61624
There are several reports of recurrent infections in patients with organic acidemia. Almost all studies on the immune system of these patients have investigated the immune system in the acidotic phase of the disease. In the present study, the phagocytic component of the immune system was evaluated in patients with organic acidemia.
Methods:
After exclusion of patients in the acidotic phase of the disease, 31 patients with organic acidemia were included in the study. All patients completed the written informed consents, and the study was approved by the ethics committee of Mofid Children’s hospital. Information including age, sex, type of organic acidemia, and history of hospitalization due to infection was recorded. Screening tests of phagocytic component of the immune system, including total and differential white blood cell (WBC) count and nitroblue tetrazolium (NBT) test, were performed for all the patients.
Results:
The prevalence of neutropenia was high among patients (22.6%); it was even more frequent in patients younger than 3 years (42.6%). On the other hand, in most patients (93.5%), neutrophils showed normal function on the NBT test.
Conclusions:
Neutropenia in the nonacidotic phase of organic acidemia can be the cause of recurrent infections in these patients. It can be independent of bone marrow suppression, caused by reduced production of these cells as a result of reduced pH in the acidotic phase of the disease.
Inborn errors of metabolism (IEMs) include a large category of disorders, which result from congenital abnormalities in the activity of enzymes, involved in the metabolism of carbohydrates, fatty acids, and amino acid cycles (1). Organic acidemia refers to a category of congenital metabolic disorders, resulting from defective activities of enzymes, involved in the metabolism of branched essential amino acids (leucine, isoleucine, and valine). It notably includes maple syrup urine disease (MSUD), isovaleric acidemia (IVA), methylmalonic acidemia (MMA), propionic acidemia (PPA), and glutaric aciduria (GA) (2). This group of disorders is characterized by the presence of organic acids in the urine and clinical presentations in newborns, including feeding difficulties, vomiting, acidosis, and dehydration (2, 3).
Pancytopenia and neutropenia have been reported as the most common immunological and hematological problems in patients with acidemia (4, 5). According to multiple reports of infections caused by different pathogens in patients with organic acidemia, there is a possibility of accompanying immunodeficiency; therefore, exploring the components of the immune system seems valuable (6-10). According to a guideline presented in 2014, evaluation of serum C-reactive protein and blood culture is essential in the acute phase of these diseases, as the patients are often immunocompromised (11).
In several studies, the immune system of patients with organic acidemia has been evaluated only in the acidotic phase of the disease (8, 12). Therefore, we aimed to evaluate the screening parameters of the immune system in 31 patients with organic acidemia in the nonacidotic phase of the disease. In our previous study, we evaluated the complement and humoral components of the immune system in these patients, including serum IgA, IgG, IgE, IgM, C3, C4, CH50, isohemagglutinin titer, antitetanus IgG, and antidiphtheria IgG (13). In the present study, we investigated the phagocytic arm of the immune system, using standard screening tests.
2. Methods
2.1. Study Population
In this study, 31 patients with organic acidemia were included. The diagnosis of organic acidemia was established, based on the patients’ clinical findings and organic acids in the body fluids. The patients’ clinical findings were compatible with the pathologically high levels of organic acids in the urine organic acid profile (studied by gas chromatography/mass spectrometry) and diagnostic acylcarnitine profile (studied by tandem mass spectrometry). The subjects were recruited based on their medical records in Mofid children’s hospital. Patients in the acute phase of the disease (acidosis), those with other diseases (e.g., infectious diseases), and those receiving corticosteroids or other immune suppressive drugs were excluded from the study. All the patients followed the required diet and received treatment of organic acidemia.
2.2. Patient Information Questionnaire
A questionnaire including the patients’ sex, age, type of organic acidemia, history of hospital admission and recurrent infections, and family history of metabolic diseases was completed according to the patients’ medical records. Patients with a history of at least 5 hospital admissions within the past year were regarded as frequently admitted patients (14). Recurrent infections were defined as 2 or more severe infections in 1 year, 3 or more respiratory infections (e.g., sinusitis, otitis, and bronchitis) in 1 year, or need for antibiotics for 2 months/year (15).
2.3. Ethical Considerations
This study was approved by the Ethics Committee of Mofid Children’s hospital, and written informed consents were obtained from all the participants.
2.4. Sample Collection
For this purpose, 1 mL of whole blood was obtained for nitroblue tetrazolium (NBT) and complete blood cell (CBC) tests with plastic 2 mL syringes, used for venipuncture with EDTA as the anticoagulant (1.5 - 2.0 mg of EDTA per mL of blood).
2.5. WBC Count
CBC and leukocyte differential counts were performed for each patient. Absolute neutrophil count (ANC) in the range of 1500 - 8000/mm3 was considered normal, and patients with ANC less than 1500 were considered neutropenic. Severity of neutropenia was defined as mild (ANC, 1000 - 1500/mm3), moderate (ANC, 500 - 1000/mm3), and severe (ANC ≤ 500/mm3) (2).
2.6. NBT Test
For this purpose, 50 μL of EDTA blood samples was mixed with 50 μL of NBT solution and incubated in a bain-marie at 37°C for 30 minutes. After incubation, the tubes were centrifuged for 3 minutes at 1500 g, and the supernatant was carefully removed. The remaining sediment was prepared as a slide and examined with a microscope after Giemsa staining. One-hundred neutrophils were counted, and the percentage of neutrophils with formazan sediments was reported. NBT more than 90% was considered normal.
2.7. Statistical Analysis
SPSS version 23 was used for statistical analyses, and correlations were examined with Spearman's correlation test at a significance level of ≤ 0.05.
3. Results
In this study, a total of 31 patients (11 patients with MSUD, 10 patients with MMA, 5 patients with IVA, 4 patients with GA, and 1 patient with PPA) were studied, among whom 14 were male and 17 were female. The mean age of the patients was 49 ± 37 months. In total, 58% of the patients had experienced hospital readmission, and 41.9% had a history of recurrent infections. Moreover, 22.6% of the patients had parents with a family history of metabolic diseases, and 74.2% had consanguineous marriages. In Table 1, the demographic data and test results of the patients are presented.
Table 1.
The Demographic Data and Test Results of the Evaluated Patients
Patients
Sex
Age, mo
Type of Organic acidemia
WBC, cell/µL
ANC, cell/µL
NBT, %
1
F
52
MMA
17200
7224
100
2
M
45
MSUD
6400
4672
80
3
M
60
IVA
7600
3648
100
4
F
83
IVA
10100
7171
95
5
F
17
MSUD
9500
3610
100
6
M
102
IVA
5900
2478
95
7
M
41
MMA
8300
4482
100
8
F
60
MSUD
11800
8496
95
9
M
9
MMA
8300
2324
95
10
M
13
MMA
6700
1340
95
11
F
37
MMA
6100
3294
90
12
F
4
MSUD
6800
680
94
13
M
20
PA
4500
900
97
14
M
30
IVA
9300
3348
100
15
M
19
MMA
7000
1890
99
16
M
144
MMA
9800
4900
100
17
F
21
MSUD
8800
5456
100
18
M
12
MSUD
9300
4092
100
19
F
66
MSUD
6000
2760
100
20
F
75
MMA
7800
6084
100
21
M
51
MSUD
5900
1239
100
22
F
84
MSUD
7300
2774
100
23
F
46
MMA
5100
1275
100
24
F
15
IVA
9200
1840
95
25
M
90
MMA
13100
7860
100
26
F
9
GA
8900
1424
99
27
M
49
MSUD
11400
7296
100
28
F
30
GA
8100
972
70
29
F
42
MSUD
7200
2304
100
30
F
144
GA
8800
5984
92
31
F
36
GA
6000
3540
89
Based on the findings, 7 (22.5%) patients had neutropenia, 4 (12.9%) had mild neutropenia, and 3 (9.6%) had moderate neutropenia. Neutropenia was more prevalent in patients younger than 3 years (42.6%; P < 0.01). As the findings revealed, 2 (6.45%) patients had abnormal NBT test results.
4. Discussion
Organic acidemia comprises a group of IEMs, associated with several clinical symptoms, including infections suggestive of immunodeficiency (16-19). In a previous study, to evaluate humoral immunity in patients with organic acidemia, serum IgA, IgM, IgG, and IgE, antitetanus, antidiphtheria IgG, and isohemagglutinin titer were measured. Moreover, to evaluate the components of the complement system, serum C3, C4, and CH50 were measured; however, no defects were detected in these parameters (13).
In the present study, the phagocytic component of the immune system was evaluated in patients with organic acidemia in the nonacidic phase, since neutropenia with or without platelet deficiency or even pancytopenia, besides infection, has been shown to be a characteristic of organic acidemia in the acidotic phase (20, 21). In multiple studies, neutropenia has been reported in some patients with organic acidemia in the acidotic phase, and many hypotheses have been proposed to explain infections and neutropenia in these patients (7, 22). In a study conducted on 33 adults and 18 newborns with PPA in the acidotic phase, neutropenia was reported in 42% and 11% of patients, respectively (21).
Similarly, in vitro studies have been performed to investigate the possible mechanisms of neutropenia in patients with organic acidemia. Inoue S. et al. in 1961 reported the dose-dependent inhibition of growth and development of bone marrow-committed stem cells in the presence of methylmalonic acids (23). In a similar study, Hutchinson RJ and colleagues revealed that acetate, propionate, and methylmalonate (to a lesser extent) induce inhibitory effects on the granulopoiesis of bone marrow granulocyte/macrophage progenitor cells (24). Meanwhile, neutropenia in the nonacidotic phase was frequent in this study, although it retained the normal function of neutrophils. In this regard, Trevani A. S. et al. reported that the acidic extracellular environment stimulates the activation of human neutrophils (25).
As the most important screening measures, CBC and NBT tests were applied to evaluate the phagocytic arm of the immune system. However, confirmation of NBT results with a more precise test (e.g., dihydrorhodamine test) would be preferable. Neutropenia in the nonacidotic phase of organic acidemia can be the cause of recurrent infections. It can be independent of bone marrow suppression, caused by reduced production of these cells as a result of reduced pH in the acidotic phase of the disease. Further studies are required to investigate the effect of pH and acidic environment on neutrophils and to identify the main cause of neutropenia in patients with organic acidemia.
Pena L,
Franks J,
Chapman KA,
Gropman A,
Ah Mew N,
Chakrapani A,
et al.
Natural history of propionic acidemia.
Mol Genet Metab. 2012; 105
(1) : 5
-9
[DOI][PubMed]
5.
Sipahi T, Yilmaz D, Tavil B. Propionic acidemia with myelodysplasia and neutropenia in a Turkish child.
J Pediatr Hematol Oncol. 2004; 26
(3) : 154
-5
[DOI][PubMed]
6.
Al Essa M,
Rahbeeni Z,
Jumaah S,
Joshi S,
Al Jishi E,
Rashed MS,
et al.
Infectious complications of propionic acidemia in Saudia Arabia.
Clin Genet. 1998; 54
(1) : 90
-4
[DOI][PubMed]
7.
Feliz B, Witt DR, Harris BT. Propionic acidemia: a neuropathology case report and review of prior cases.
Arch Pathol Lab Med. 2003; 127
(8) : e325
-8
[DOI][PubMed]
8.
Muller S, Falkenberg N, Monch E, Jakobs C. Propionacidaemia and immunodeficiency.
Lancet. 1980; 1
(8167) : 551
-2
[DOI][PubMed]
9.
Ozand PT,
Rashed M,
Gascon GG,
Youssef NG,
Harfi H,
Rahbeeni Z,
et al.
Unusual presentations of propionic acidemia.
Brain Dev. 1994; 16 Suppl
: 46
-57
[DOI][PubMed]
10.
van der Meer SB,
Poggi F,
Spada M,
Bonnefont JP,
Ogier H,
Hubert P,
et al.
Clinical outcome and long-term management of 17 patients with propionic acidaemia.
Eur J Pediatr. 1996; 155
(3) : 205
-10
[PubMed]
11.
Baumgartner MR,
Horster F,
Dionisi-Vici C,
Haliloglu G,
Karall D,
Chapman KA,
et al.
Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia.
Orphanet J Rare Dis. 2014; 9
: 130
[DOI][PubMed]
12.
Church JA, Koch R, Shaw KN, Nye CA, Donnell GN. Immune functions in methylmalonicaciduria.
J Inherit Metab Dis. 1984; 7
(1) : 12
-4
[DOI][PubMed]
13.
Alizadeh Najjarbashi F, Mesdaghi M, Alaei M, Shakiba M, Jami A, Ghadimi F. A Study on the Humoral and Complement Immune System of Patients with Organic Acidemia.
Iran J Allergy Asthma Immunol. 2015; 14
(6) : 638
-41
[PubMed]
14.
Szekendi MK, Williams MV, Carrier D, Hensley L, Thomas S, Cerese J. The characteristics of patients frequently admitted to academic medical centers in the United States.
J Hosp Med. 2015; 10
(9) : 563
-8
[DOI][PubMed]
15.
Uptodate . Approach to the child with recurrent infections. 2015;
16.
Okano M, Kishiyama K, Satake N, Kubo S, Ishikawa N. A case of fulminant ecthyma gangrenosum associated with Pseudomonas aeruginosa infection in a patient with methylmalonic acidemia.
Scand J Infect Dis. 1994; 26
(1) : 107
-8
[DOI][PubMed]
17.
Werlin SL. E. coli sepsis as a presenting sign in neonatal propionic acidemia.
Am J Med Genet. 1993; 46
(4) : 455
-6
[DOI][PubMed]
18.
Nakamura M, Tokura Y. Methylmalonic aciduria presenting with recurrent multiple molluscum contagiosum lesions.
Dermatoendocrinol. 2010; 2
(2) : 60
-1
[DOI][PubMed]
Grunert SC,
Mullerleile S,
de Silva L,
Barth M,
Walter M,
Walter K,
et al.
Propionic acidemia: neonatal versus selective metabolic screening.
J Inherit Metab Dis. 2012; 35
(1) : 41
-9
[DOI][PubMed]
22.
Childs B, Nyhan WL, Borden M, Bard L, Cooke RE. Idiopathic hyperglycinemia and hyperglycinuria: a new disorder of amino acid metabolism. I.
Pediatrics. 1961; 27
: 522
-38
[PubMed]
23.
Inoue S, Krieger I, Sarnaik A, Ravindranath Y, Fracassa M, Ottenbreit MJ. Inhibition of bone marrow stem cell growth in vitro by methylmalonic acid: a mechanism for pancytopenia in a patient with methylmalonic acidemia.
Pediatr Res. 1981; 15
(2) : 95
-8
[DOI][PubMed]
24.
Hutchinson RJ, Bunnell K, Thoene JG. Suppression of granulopoietic progenitor cell proliferation by metabolites of the branched-chain amino acids.
J Pediatr. 1985; 106
(1) : 62
-5
[DOI][PubMed]
25.
Trevani AS,
Andonegui G,
Giordano M,
Lopez DH,
Gamberale R,
Minucci F,
et al.
Extracellular acidification induces human neutrophil activation.
J Immunol. 1999; 162
(8) : 4849
-57
[PubMed]
LEAVE A COMMENT HERE: